Skip to main content
Inpatient Procedure Code

3E0H83Z ICD-10-PCS Code: Introduction of Anti-inflammatory into Lower GI, Via Natural or Artificial Opening Endoscopic

Introduction of Anti-inflammatory into Lower GI, Endo

Axis Breakdown

Every ICD-10-PCS code is exactly seven characters, one per axis. Each character's meaning is defined by its position in the code.

PositionValueMeaning
1
Section3

Administration

2
Body SystemE

Physiological Systems and Anatomical Regions

3
Root Operation0

Introduction

Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products

4
Body System / RegionH

Lower GI

5
Approach8

Via Natural or Artificial Opening Endoscopic

6
Substance3

Anti-inflammatory

7
QualifierZ

No Qualifier

Related Codes

Same operation — other Body System / Region

Same table and root operation, differing only in the body system / region character.

3E0E83Z — Introduction of Anti-inflammatory into Products of Conception, Via Natural or Artificial Opening Endoscopic, 3E0F83Z — Introduction of Anti-inflammatory into Respiratory Tract, Via Natural or Artificial Opening Endoscopic, 3E0G83Z — Introduction of Anti-inflammatory into Upper GI, Via Natural or Artificial Opening Endoscopic, 3E0J83Z — Introduction of Anti-inflammatory into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic, 3E0K83Z — Introduction of Anti-inflammatory into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic, 3E0N83Z — Introduction of Anti-inflammatory into Male Reproductive, Via Natural or Artificial Opening Endoscopic, 3E0P83Z — Introduction of Anti-inflammatory into Female Reproductive, Via Natural or Artificial Opening Endoscopic

Same operation — other Approach

Same table and root operation, differing only in the approach character.

3E0H33Z — Introduction of Anti-inflammatory into Lower GI, Percutaneous Approach, 3E0H73Z — Introduction of Anti-inflammatory into Lower GI, Via Natural or Artificial Opening

Same operation — other Substance

Same table and root operation, differing only in the substance character.

3E0H86Z — Introduction of Nutritional Substance into Lower GI, Via Natural or Artificial Opening Endoscopic, 3E0H87Z — Introduction of Electrolytic and Water Balance Substance into Lower GI, Via Natural or Artificial Opening Endoscopic, 3E0H8BZ — Introduction of Anesthetic Agent into Lower GI, Via Natural or Artificial Opening Endoscopic, 3E0H8HZ — Introduction of Radioactive Substance into Lower GI, Via Natural or Artificial Opening Endoscopic, 3E0H8KZ — Introduction of Other Diagnostic Substance into Lower GI, Via Natural or Artificial Opening Endoscopic, 3E0H8NZ — Introduction of Analgesics, Hypnotics, Sedatives into Lower GI, Via Natural or Artificial Opening Endoscopic, 3E0H8TZ — Introduction of Destructive Agent into Lower GI, Via Natural or Artificial Opening Endoscopic

Same procedure category (CCSR), other tables

AHRQ's Clinical Classifications Software Refined groups these ICD-10-PCS procedures with this one under Administration of anti-inflammatory agents (Administration of Therapeutic Substances); listed here are the members in other PCS tables. Source: Clinical Classifications Software Refined (CCSR), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality, November 2025.

XW03308 — Introduction of Spesolimab Monoclonal Antibody into Peripheral Vein, Percutaneous Approach, New Technology Group 8, XW03357 — Introduction of Narsoplimab Monoclonal Antibody into Peripheral Vein, Percutaneous Approach, New Technology Group 7, XW03398 — Introduction of Inebilizumab-cdon into Peripheral Vein, Percutaneous Approach, New Technology Group 8, XW04308 — Introduction of Spesolimab Monoclonal Antibody into Central Vein, Percutaneous Approach, New Technology Group 8, XW04357 — Introduction of Narsoplimab Monoclonal Antibody into Central Vein, Percutaneous Approach, New Technology Group 7, XW04398 — Introduction of Inebilizumab-cdon into Central Vein, Percutaneous Approach, New Technology Group 8, XW0DXR7 — Introduction of Fostamatinib into Mouth and Pharynx, External Approach, New Technology Group 7, XW0G7R7 — Introduction of Fostamatinib into Upper GI, Via Natural or Artificial Opening, New Technology Group 7, XW0H7R7 — Introduction of Fostamatinib into Lower GI, Via Natural or Artificial Opening, New Technology Group 7

Contextual Map

Every relationship of 3E0H83Z in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.

PCS table

Clinical classification (CCSR)

Nearest codes

Change history

No changes recorded for this code. This ledger tracks additions, deletions and description changes from FY2026 (April) onward. Note changes are not tracked.

Read from: CMS ICD-10-PCS code tables, index and definitions — FY2026 (April); CMS MS-DRG Definitions Manual (incl. Appendix B diagnosis index, Appendix C CC/MCC list, Appendix E procedure index) and IPPS Final Rule tables — v43; AHRQ HCUP Clinical Classifications Software Refined for ICD-10-PCS Procedures (hcup-us.ahrq.gov/toolssoftware/ccsr/PRCCSR_v2026-1.zip) — v2026.1. All data sources · How to read the labels